/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Altimmune Inc Share Price Today: Live Updates & Key Insights

Altimmune Inc share price today is $3.4, up -2.34%. The stock opened at $3.43 against the previous close of $3.42, with an intraday high of $3.515 and low of $3.31.

Altimmune Inc Share Price Chart

style
pb-0

Altimmune Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Altimmune Inc Share Price Performance

$3.4 -0.0234(-2.34%) ALT at 23 Mar 2026 11:58 AM Biotechnology
Lowest Today 3.31
Highest Today 3.515
Today’s Open 3.43
Prev. Close 3.42
52 Week High 7.73
52 Week Low 2.90
Day’s Range: Low 3.31 High 3.515
52-Week Range: Low 2.90 High 7.73
1 day return -
1 Week return -7.31
1 month return -25.49
3 month return -18.74
6 month return -15.04
1 year return -44.37
3 year return -19.8
5 year return -78.74
10 year return -

Altimmune Inc Institutional Holdings

Vanguard Group Inc 7.30

BlackRock Inc 4.90

State Street Corp 2.77

Vanguard Total Stock Mkt Idx Inv 2.52

State Street® SPDR® S&P® Biotech ETF 2.51

Geode Capital Management, LLC 1.76

TANG CAPITAL MANAGEMENT LLC 1.64

iShares Russell 2000 ETF 1.64

Jane Street Group LLC 1.37

Vanguard Strategic Equity Inv 1.21

Morgan Stanley - Brokerage Accounts 1.15

Nuveen Quant Small Cap Equity R6 1.11

Susquehanna International Group, LLP 1.05

D. E. Shaw & Co LP 1.03

Citadel Advisors Llc 1.03

Two Sigma Investments LLC 0.97

Nuveen, LLC 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Knoll Capital Management LP 0.86

iShares Biotechnology ETF 0.72

Marshall Wace Asset Management Ltd 0.71

Fidelity Small Cap Index 0.67

Two Sigma Advisers, LLC 0.61

Vanguard Explorer Inv 0.59

iShares Russell 2000 Growth ETF 0.57

Northern Trust Corp 0.51

UBS Group AG 0.49

Vanguard Strategic Small-Cap Equity Inv 0.48

BlackRock Advantage Small Cap Core Instl 0.46

FMR Inc 0.43

The Goldman Sachs Group Inc 0.43

Fidelity Extended Market Index 0.42

Fidelity Enhanced Small Cap ETF 0.42

State St Russell Sm/Mid Cp® Indx SL Cl I 0.42

Point72 Asset Management, L.P. 0.37

Vanguard Russell 2000 ETF 0.32

Blackrock Extended Mkt Fund CF 0.22

Vanguard VIF Small Co Gr 0.21

State St Russell Sm Cap® Indx SL Cl I 0.21

Vanguard Health Care ETF 0.21

Altimmune Inc Market Status

Strong Buy: 5

Buy: 3

Hold: 1

Sell: 0

Strong Sell: 0

Altimmune Inc Fundamentals

Market Cap 434.55 M

PB Ratio 1.9438

PE Ratio 0.0

Enterprise Value 199.39 M

Total Assets 279.93 M

Volume 12523672

Altimmune Inc Company Financials

Annual Revenue FY23:279000 0.3M, FY22:-68000 -0.1M, FY21:4410356 4.4M, FY20:8185027 8.2M, FY19:5801401 5.8M

Annual Profit FY23:null 0.0M, FY22:-68000 -0.1M, FY21:4410356 4.4M, FY20:8185027 8.2M, FY19:5801401 5.8M

Annual Net worth FY23:-78466000 -78.5M, FY22:-84713000 -84.7M, FY21:-96171311 -96.2M, FY20:-49044477 -49.0M, FY19:-20520131 -20.5M

Quarterly Revenue Q3/2025:5000 0.0M, Q2/2025:5000 0.0M, Q1/2025:5000 0.0M, Q3/2024:5000 0.0M, Q2/2024:5000 0.0M

Quarterly Profit Q3/2025:-14955000 -15.0M, Q2/2025:5000 0.0M, Q1/2025:5000 0.0M, Q3/2024:5000 0.0M, Q2/2024:-56000 -0.1M

Quarterly Net worth Q3/2025:-19014000 -19.0M, Q2/2025:-22146000 -22.1M, Q1/2025:-19575000 -19.6M, Q3/2024:-22845000 -22.8M, Q2/2024:-24640000 -24.6M

About Altimmune Inc & investment objective

Company Information Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Organisation Biotechnology

Employees 57

Industry Biotechnology

CEO Mr. Jerome Benedict Durso

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Altimmune Inc FAQs

What is the share price of Altimmune Inc today?

The current share price of Altimmune Inc is $3.4.

Can I buy Altimmune Inc shares in India?

Yes, Indian investors can buy Altimmune Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Altimmune Inc shares in India?

You can easily invest in Altimmune Inc shares from India by:

Can I buy fractional shares of Altimmune Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Altimmune Inc?

Altimmune Inc has a market cap of $434.55 M.

In which sector does Altimmune Inc belong?

Altimmune Inc operates in the Biotechnology sector.

What documents are required to invest in Altimmune Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Altimmune Inc?

The PE ratio of Altimmune Inc is N/A and the PB ratio is 1.94.